Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Division of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco, Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy.
Respir Med. 2018 Dec;145:120-129. doi: 10.1016/j.rmed.2018.10.031. Epub 2018 Nov 2.
International guidelines recommend simple spirometry for bronchiectasis patients. However, pulmonary pathophysiology of bronchiectasis is very complex and still poorly understood. Our objective was to characterize lung function in bronchiectasis and identify specific functional sub-groups.
This was a multicenter, prospective, observational study enrolling consecutive adults with bronchiectasis during stable sate. Patients underwent body-plethysmography before and after acute bronchodilation testing, diffusing lung capacity (DLCO) with a 3-year follow up. Air trapping and hyperinflation were a residual volume (RV) > 120%predicted and a total lung capacity>120%predicted. Acute reversibility was: ΔFEV1 ≥12% and 200 mL from baseline (FEV1rev) and ΔRV ≥10% reduction from baseline (RVrev). Sensitivity analyses included different reversibility cutoffs and excluded patients with concomitant asthma or chronic obstructive pulmonary disease.
187 patients were enrolled (median age: 68 years; 29.4% males). Pathophysiological abnormalities often overlapped and were distributed as follows: air trapping (70.2%), impaired DLCO (55.7%), airflow obstruction (41.1%), hyperinflation (15.7%) and restriction (8.0%). 9.7% of patients had normal lung function. RVrev (17.6%) was more frequent than FEV1rev (4.3%). Similar proportions were found after multiple sensitivity analyses. Compared with non-reversible patients, patients with RVrev had more severe obstruction (mean(SD) FEV1%pred: 83.0% (24.4) vs 68.9% (26.2); P = 0.02) and air trapping (RV%pred, 151.9% (26.6) vs 166.2% (39.9); P = 0.028).
Spirometry alone does not encompass the variety of pathophysiological characteristics in bronchiectasis. Air trapping and diffusion impairment, not airflow obstruction, represent the most common functional abnormalities. RVrev is related to worse lung function and might be considered in bronchiectasis' workup and for patients' functional stratification.
国际指南建议对支气管扩张症患者进行简单的肺功能检查。然而,支气管扩张症的肺病理生理学非常复杂,目前仍了解甚少。我们的目的是描述支气管扩张症患者的肺功能,并确定特定的功能亚组。
这是一项多中心、前瞻性、观察性研究,纳入了稳定期的支气管扩张症成年患者。患者在急性支气管扩张试验前后进行体描法检查,在 3 年的随访中进行弥散肺量(DLCO)检查。空气潴留和过度充气的标准为残气量(RV)>预测值的 120%和肺总量>预测值的 120%。急性可逆性定义为:FEV1 增加≥12%和 200ml (FEV1rev)和 RV 减少≥基线值的 10%(RVrev)。敏感性分析包括不同的可逆性截断值,并排除了同时患有哮喘或慢性阻塞性肺疾病的患者。
共纳入 187 例患者(中位年龄:68 岁;29.4%为男性)。病理生理学异常经常重叠,分布如下:空气潴留(70.2%)、DLCO 受损(55.7%)、气流受限(41.1%)、过度充气(15.7%)和限制(8.0%)。9.7%的患者肺功能正常。RVrev(17.6%)比 FEV1rev(4.3%)更常见。多项敏感性分析后也得到了相似的结果。与不可逆患者相比,RVrev 患者的阻塞更严重(平均(SD)FEV1%预测值:83.0%(24.4)vs 68.9%(26.2);P=0.02),空气潴留也更严重(RV%预测值,151.9%(26.6)vs 166.2%(39.9);P=0.028)。
单独的肺功能检查不能涵盖支气管扩张症的各种病理生理学特征。空气潴留和弥散功能障碍,而不是气流受限,代表最常见的功能异常。RVrev 与更差的肺功能相关,可能在支气管扩张症的检查和患者的功能分层中被考虑。